|
Re: Globe n Mail this am.
|
2
|
Zenith Epigenetics
|
Feb 03, 2018 11:49AM
|
|
Re: Updated Analyst Report from Marcel Wijma, Van Leeuwenhoeck Institute
|
6
|
Resverlogix Corp.
|
Feb 02, 2018 12:37PM
|
|
Re: A couple from the "Cardiology Top 10" this month.
|
|
Resverlogix Corp.
|
Feb 02, 2018 12:14PM
|
|
Re: A couple from the "Cardiology Top 10" this month.
|
1
|
Resverlogix Corp.
|
Feb 02, 2018 03:13AM
|
|
Re: Interesting Observation
|
|
Resverlogix Corp.
|
Feb 02, 2018 02:44AM
|
|
Interesting Observation
|
5
|
Resverlogix Corp.
|
Feb 01, 2018 06:58PM
|
|
Re: Zenith Epigentics and Resverlogix update 22 Jan 2018
|
2
|
Resverlogix Corp.
|
Feb 01, 2018 12:09PM
|
|
Re: Zenith Epigentics and Resverlogix update 22 Jan 2018
|
5
|
Zenith Epigenetics
|
Feb 01, 2018 12:04PM
|
|
Zenith Epigentics and Resverlogix update 22 Jan 2018
|
2
|
Zenith Epigenetics
|
Jan 31, 2018 04:03PM
|
|
Zenith Epigentics and Resverlogix update 22 Jan 2018
|
14
|
Resverlogix Corp.
|
Jan 31, 2018 04:00PM
|
|
Re: BETonMACE top line data
|
5
|
Resverlogix Corp.
|
Jan 18, 2018 01:00AM
|
|
Re: BETonMACE top line data
|
4
|
Resverlogix Corp.
|
Jan 17, 2018 12:13AM
|
|
Re: BETonMACE top line data
|
10
|
Resverlogix Corp.
|
Jan 16, 2018 06:26PM
|
|
Re: BETonMACE top line data
|
2
|
Resverlogix Corp.
|
Jan 16, 2018 12:48PM
|
|
Re: BETonMACE top line data
|
4
|
Resverlogix Corp.
|
Jan 16, 2018 09:55AM
|
|
Re: ZEN-3694 Single Agent Trial Status
|
6
|
Zenith Epigenetics
|
Jan 16, 2018 09:22AM
|
|
Re: BETonMACE top line data
|
6
|
Resverlogix Corp.
|
Jan 16, 2018 12:58AM
|
|
Re: ZEN-3694 Single Agent Trial Status
|
7
|
Zenith Epigenetics
|
Jan 16, 2018 12:22AM
|
|
Re: Isreal Deal
|
1
|
Resverlogix Corp.
|
Jan 13, 2018 10:24PM
|
|
Re: Isreal Deal
|
6
|
Resverlogix Corp.
|
Jan 13, 2018 12:36AM
|
